Advertisement
ALDX vs CTMX
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALDX is a Buy and CTMX is a Buy.
ALDX's Stochastic Oscillator stays in oversold zone for 18 days
The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where ALDX's RSI Oscillator exited the oversold zone, 26 of 33 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 79%.
The Moving Average Convergence Divergence (MACD) for ALDX just turned positive on October 28, 2026. Looking at past instances where ALDX's MACD turned positive, the stock continued to rise in 34 of 41 cases over the following month. The odds of a continued upward trend are 83%.
ALDX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ALDX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 78%.
The Aroon Indicator for ALDX entered a downward trend on October 28, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 8 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 37 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.089) is normal, around the industry mean (3.151). P/E Ratio (-1.799) is within average values for comparable stocks, (-1.051). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (127.720) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (439.237).
The Tickeron Price Growth Rating for this company is 94 (best 1 - 100 worst), indicating slightly worse than average price growth. ALDX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ALDX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
CTMX in upward trend: price expected to rise as it breaks its lower Bollinger Band on October 13, 2026
CTMX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 42 of 45 cases where CTMX's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where CTMX's RSI Oscillator exited the oversold zone, 36 of 43 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 84%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
The Momentum Indicator moved above the 0 level on October 28, 2026. You may want to consider a long position or call options on CTMX as a result. In 67 of 86 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 78%.
The Moving Average Convergence Divergence (MACD) for CTMX just turned positive on October 20, 2026. Looking at past instances where CTMX's MACD turned positive, the stock continued to rise in 29 of 43 cases over the following month. The odds of a continued upward trend are 67%.
Following a +6.07% 3-day Advance, the price is estimated to grow further. Considering data from situations where CTMX advanced for three days, in 182 of 235 cases, the price rose further within the following month. The odds of a continued upward trend are 77%.
Bearish Trend Analysis
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CTMX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 88%.
The Aroon Indicator for CTMX entered a downward trend on October 28, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 27 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.702) is normal, around the industry mean (3.151). P/E Ratio (-4.140) is within average values for comparable stocks, (-1.051). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (127.720) among similar stocks. P/S Ratio (27.624) is also within normal values, averaging (439.237).
The Tickeron Price Growth Rating for this company is 82 (best 1 - 100 worst), indicating slightly worse than average price growth. CTMX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 97 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 98 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CTMX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
ALDX | CTMX | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 54 | 3 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 37 Fair valued | 27 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 98 | 97 | |
PRICE GROWTH RATING 1..100 | 94 | 82 | |
P/E GROWTH RATING 1..100 | 8 | 98 | |
SEASONALITY SCORE 1..100 | 50 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
CTMX's Valuation (27) in the Biotechnology industry is in the same range as ALDX (37). This means that CTMX’s stock grew similarly to ALDX’s over the last 12 months.
CTMX's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as ALDX (100). This means that CTMX’s stock grew similarly to ALDX’s over the last 12 months.
CTMX's SMR Rating (97) in the Biotechnology industry is in the same range as ALDX (98). This means that CTMX’s stock grew similarly to ALDX’s over the last 12 months.
CTMX's Price Growth Rating (82) in the Biotechnology industry is in the same range as ALDX (94). This means that CTMX’s stock grew similarly to ALDX’s over the last 12 months.
ALDX's P/E Growth Rating (8) in the Biotechnology industry is significantly better than the same rating for CTMX (98). This means that ALDX’s stock grew significantly faster than CTMX’s over the last 12 months.
| ALDX | CTMX | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 79% | 1 day ago 84% |
| Stochastic ODDS (%) | 1 day ago 85% | 1 day ago 74% |
| Momentum ODDS (%) | N/A | 1 day ago 78% |
| MACD ODDS (%) | 1 day ago 83% | 1 day ago 67% |
| TrendWeek ODDS (%) | 1 day ago 84% | 1 day ago 86% |
| TrendMonth ODDS (%) | 1 day ago 80% | 1 day ago 87% |
| Advances ODDS (%) | N/A | 1 day ago 77% |
| Declines ODDS (%) | 3 days ago 78% | 4 days ago 88% |
| BollingerBands ODDS (%) | 1 day ago 76% | 1 day ago 90% |
| Aroon ODDS (%) | 1 day ago 90% | 1 day ago 84% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ALDX’s FA Score shows that 1 FA rating(s) are green while CTMX’s FA Score has 1 green FA rating(s).
- ALDX’s FA Score: 1 green, 4 red.
- CTMX’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ALDX’s TA Score shows that 4 TA indicator(s) are bullish while CTMX’s TA Score has 6 bullish TA indicator(s).
- ALDX’s TA Score: 4 bullish, 2 bearish.
- CTMX’s TA Score: 6 bullish, 2 bearish.
Price Growth
ALDX (@Biotechnology) experienced а +1.98% price change this week, while CTMX (@Biotechnology) price change was -1.67% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was +1.47%. For the same industry, the average monthly price growth was -10.85%, and the average quarterly price growth was -12.11%.
Reported Earning Dates
ALDX is expected to report earnings on Nov 04, 2026.
CTMX is expected to report earnings on Nov 05, 2026.
Industries' Descriptions
@Biotechnology (+1.47% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
Advertisement
ALDX and
Correlation & Price change
A.I.dvisor indicates that over the last year, ALDX has been loosely correlated with CLLS. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if ALDX jumps, then CLLS could also see price increases.
| Ticker / NAME | Correlation To ALDX | 1D Price Change % | ||
|---|---|---|---|---|
| ALDX | 100% | +6.61% | ||
| CLLS - ALDX | 39% Loosely correlated | +20.00% | ||
| ARVN - ALDX | 37% Loosely correlated | +2.01% | ||
| CTMX - ALDX | 36% Loosely correlated | +2.16% | ||
| MTNB - ALDX | 36% Loosely correlated | +4.37% | ||
| OTLK - ALDX | 35% Loosely correlated | +2.85% | ||
More | ||||
CTMX and
Correlation & Price change
A.I.dvisor indicates that over the last year, CTMX has been loosely correlated with MLEC. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if CTMX jumps, then MLEC could also see price increases.
| Ticker / NAME | Correlation To CTMX | 1D Price Change % | ||
|---|---|---|---|---|
| CTMX | 100% | +2.16% | ||
| MLEC - CTMX | 42% Loosely correlated | +2.72% | ||
| EDIT - CTMX | 40% Loosely correlated | +13.46% | ||
| IMTX - CTMX | 40% Loosely correlated | +1.24% | ||
| VKTX - CTMX | 38% Loosely correlated | +1.89% | ||
| VIR - CTMX | 37% Loosely correlated | +3.11% | ||
More | ||||